McGlinn Cancer Institute — West Reading, Pennsylvania

McGlinn Cancer Institute is a clinical research site located in West Reading, Pennsylvania, United States 19611-2143.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

McGlinn Cancer Institute has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Mantle Cell Lymphoma, B Cell Lymphoma.

Sponsors: BeOne Medicines.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for McGlinn Cancer Institute?

McGlinn Cancer Institute has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has McGlinn Cancer Institute conducted?

McGlinn Cancer Institute has 1 clinical trials on record, with 1 currently active. Their work covers Mantle Cell Lymphoma, B Cell Lymphoma.

Is McGlinn Cancer Institute accredited by Crixeo Health?

McGlinn Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about McGlinn Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.